Maprotiline
- Generic Name
- Maprotiline
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H23N
- CAS Number
- 10262-69-8
- Unique Ingredient Identifier
- 2U1W68TROF
- Background
Maprotiline is a tetracyclic antidepressant with similar pharmacological properties to tricyclic antidepressants (TCAs). Similar to TCAs, maprotiline inhibits neuronal norepinephrine reuptake, possesses some anticholinergic activity, and does not affect monoamine oxidase activity. It differs from TCAs in that it does not appear to block serotonin reuptake. M...
- Indication
For treatment of depression, including the depressed phase of bipolar depression, psychotic depression, and involutional melancholia, and may also be helpful in treating certain patients suffering severe depressive neurosis.
- Associated Conditions
- Anxiety, Bipolar Disorder (BD), Depression, Major Depressive Disorder (MDD), Persistent Depressive Disorder (Dysthymia)
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath